Now approved for risk reductions in patients with type 2 diabetes mellitus.
Cost, education, self-monitoring, and more.
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
How pipeline promises—and disappointments—are impacting patients with diabetes.
New drug combines dapagliflozin, saxagliptin, and metformin.
Increase adherence by matching technology to each patient's unique needs.
Consumers are using test strips that might lead to inaccurate results.
Eli Lilly creates generic Humalog priced 50% lower
Rounding up the news you need to know to start the new year.
GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management.